AnalystsRoanna RuizRoanna Ruiz's Stock Forecasts
AnalystsRoanna Ruiz
Analyst Ranking
Bottom 3%
#4789 out of 4929 analysts
Average Return
-22.34%
Win Rate
31%14 out of 45
Risk vs Reward
Poor
Good
Roanna Ruiz's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Xeris Biopharma Holdings IncXERS | +97.62% | $1.26 | $2.49 | 2023-01-26 - 2024-01-26 | Buy |
Cytokinetics IncCYTK | +70.83% | $32.71 | $55.88 | 2023-08-14 - 2024-08-14 | Buy |
United Therapeutics CorpUTHR | +66.12% | $212.76 | $353.43 | 2024-02-04 - 2025-02-04 | Buy |
Myovant Sciences LtdMYOV | +60.19% | $16.68 | $26.72 | 2022-08-08 - 2022-10-25 | Buy |
Akebia Therapeutics IncAKBA | +48.97% | $2.43 | $3.62 | 2025-04-27 - 2025-07-03 | Buy |
Roanna Ruiz Analyst Color
Get additional color on Roanna Ruiz's coverage of popular stocks
Roanna Ruiz's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Akebia Therapeutics IncAKBA | 1 | Buy | $7.00 | +93.37% | Initiates Coverage On | 2 months ago |
Xeris Biopharma Holdings IncXERS | 5 | Buy | $6.00 | +26.32% | Maintains | 4 months ago |
Cormedix IncCRMD | 1 | Buy | $18.00 | +54.91% | Initiates Coverage On | 4 months ago |
Lexicon Pharmaceuticals IncLXRX | 1 | Hold | $1.00 | +10.99% | Downgrades | 4 months ago |
Vir Biotechnology IncVIR | 4 | Buy | $20.00 | +269.69% | Maintains | 6 months ago |
Ars Pharmaceuticals IncSPRY | 4 | Buy | $27.00 | +63.44% | Maintains | 6 months ago |
Aquestive Therapeutics IncAQST | 3 | Buy | $13.00 | +249.46% | Maintains | 8 months ago |
Ardelyx IncARDX | 1 | Buy | $14.00 | N/A | Initiates Coverage On | a year ago |
United Therapeutics CorpUTHR | 1 | Buy | $330.00 | N/A | Initiates Coverage On | a year ago |
Cytokinetics IncCYTK | 1 | Buy | $58.00 | N/A | Initiates Coverage On | 2 years ago |
Corcept Therapeutics IncCORT | 1 | Hold | $25.00 | N/A | Initiates Coverage On | 2 years ago |
Pardes Biosciences IncPRDS | 4 | Hold | $2.00 | N/A | Downgrades | 2 years ago |
Enanta Pharmaceuticals IncENTA | 10 | Hold | $49.00 | N/A | Reiterates | 2 years ago |
Scpharmaceuticals IncSCPH | 5 | Buy | $13.00 | N/A | Maintains | 2 years ago |
Atea Pharmaceuticals IncAVIR | 6 | Hold | $6.00 | N/A | Maintains | 2 years ago |
Newamsterdam Pharma Co NvNAMS | 1 | Buy | $19.00 | N/A | Initiates Coverage On | 3 years ago |
Lantheus Holdings IncLNTH | 3 | Buy | $120.00 | N/A | Maintains | 3 years ago |
Aligos Therapeutics IncALGS | 7 | Hold | $50.00 | N/A | Maintains | 3 years ago |
Myovant Sciences LtdMYOV | 7 | Hold | $27.00 | N/A | Downgrades | 3 years ago |
Amarin Corp PLCAMRN | 6 | Hold | $40.00 | N/A | Maintains | 3 years ago |
Contrafect CorpCFRXQ | 3 | Hold | $80.00 | N/A | Downgrades | 3 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.